drugset / Trial / NCT03306615

Peripheral Modulation of Muscle Stiffness and Spasticity

NCT03306615

Phase 2 Active not recruiting 56 enrolled Johns Hopkins University Sheikh Khalifa Stroke Institute · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a single-center, double-blind, randomized, placebo-controlled, sequential Phase II trial of human recombinant hyaluronidase injections in individuals with post-stroke upper limb muscle stiffness. The investigators will recruit 56 subjects, who will be randomized to receive either the intervention or normal saline injections (first injection), and then the intervention the participants did not receive first (second injection). All individuals will receive the treatment by the end of the study.

Timeline

Start
2021-10-11
Primary completion
2026-06-26
Completion
2027-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject rHuPH20 Protein / enzyme biologic Intramuscular

Indications

No indication recorded.